GILD

Gilead Sciences Inc
$134.43 -1.31%

Recent alerts on GILD

All signals →
News Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More
3d ago
News Gilead's Hepcludex wins FDA approval for chronic HDV infection
10d ago
News AbbVie, Merck, Astra among winners of EU drug recommendations this week
11d ago
News Assembly Biosciences prices $100M equity offering
11d ago
News A Healthy Return: Drug Spin-off Nets Keymed Up To $320M
14d ago
News Software Slump Resumes, Bitcoin Plunges To $66,000: What's Moving Markets Wednesday?
14d ago
News Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing
14d ago
News This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
14d ago
News Biotech Sector May Flip to Market Leader by Year-End
14d ago
News Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy
14d ago
News Kymera Revenue Drops 55 Percent in Q2
14d ago
News MacroGenics Revenue Doubles in Q2
14d ago
News IDEAYA (IDYA) Q2 Net Loss Improves 27%
14d ago
News Tango (TNGX) Q2 Revenue Drops 52%
14d ago
News Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales
14d ago
News Why Gilead Scinces Stock Tumbled on Tuesday
14d ago
News Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
14d ago
News Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
14d ago
News Gilead Sciences Beats Q4 EPS Forecast
14d ago
News Why Gilead Sciences Stock Is Jumping Today
14d ago
News Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
14d ago
News Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
14d ago
News After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment
14d ago
News Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks
14d ago
News Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
14d ago

Get push alerts for GILD

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS